BRD9 Antilichaam - N-terminalgebied: FITC (ARP34803_T100-FITC)

Bromodomain containing 9

PRO9856, LAVS3040

65980

Q9H8M2

NP_001009877

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Zebrafish

The immunogen is a synthetic peptide directed towards the N terminal region of human BRD9

BRD9 is a member of protein family that contains bromodomain. It is potentially related to cancer.

CATIP; SUMO2

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

BRD9 is supported by BioGPS gene expression data to be expressed in Jurkat

0.5 mg/ml

Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 92%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 77%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

53kDa

Clark, H.F., et al., (2003) Genome Res. 13 (10), 2265-2270

Wet Ice

481

BRD9

BRD9

Rabbit

Bromodomain-containing protein 9

NM_001009877

VTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKQAALLGNE